Aevumed Inc. is raising up to $1.23M on Dealmaker Securities LLC in common stock at $9 each; in its filing revenue was $683K and it had 9 employees (Form C, 2025-09-08).
Aevumed Inc. filed a Regulation Crowdfunding offering with the SEC through Dealmaker Securities LLC, with a target of $10K and a maximum of $1.23M. As of November 7, 2026, the offering is past its deadline of August 28, 2026. The company gives its address as Malvern, PA (Form C, September 8, 2025).
Sell to companies like Aevumed Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Intermediary: Dealmaker Securities LLC · Target: $10K · Maximum: $1.23M · Deadline: 2026-08-28 · Security: Common Stock · C
- · What: Private placement (Form D) · Amount as filed: $1.50M sold of $1.50M offered · filing
- · What: Private placement (Form D) · Amount as filed: $264K sold of $264K offered · filing
- · What: Private placement (Form D) · Amount as filed: $305K sold of $305K offered · filing
- · What: Private placement (Form D) · Amount as filed: $3M sold of $3M offered · filing
Aevumed Inc., based in Malvern, PA, filed a Regulation Crowdfunding offering with the SEC, the latest on 2025-09-08, raising through Dealmaker Securities LLC. It set a target of $10K and will accept up to $1.23M. The security offered is common stock at $9 each. As of its filings the offering is past its deadline of 2026-08-28. 1 filing in this family are on record for the company.
Terms at a glance
| Target | $10K |
| Maximum it will accept | $1.23M |
| Security | Common Stock |
| Price per unit | $9 |
| Units at the target | 1,111 |
| Raise above the target | accepted, other |
| Deadline | 2026-08-28 |
| Raising through | Dealmaker Securities LLC |
| What the portal is paid, as filed | An Activation/Setup Fee of $11,375, Monthly Subscription Fee of $2,000 per month, Usage Fee 8.5% of proceeds raised will be payable to the intermediary and/or its affiliates. |
Check before you invest in Aevumed Inc.: who signed the filing and its own figures, free.
Free to see. No signup.
Want the whole picture on Aevumed Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Aevumed Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Aevumed Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
The filing does not state a company valuation or a minimum investment; the offering page on Dealmaker Securities LLC shows those. Check both before you invest.
Money raised before
Earlier raises by this company that are on file, with the amounts as filed. A figure for a raise is what the company reported, not a check of what it received.
| Filed | What | Amount as filed | Filing |
|---|---|---|---|
| 2025-06-12 | Private placement (Form D) | $1.50M sold of $1.50M offered | filing |
| 2025-06-12 | Private placement (Form D) | $264K sold of $264K offered | filing |
| 2025-06-12 | Private placement (Form D) | $305K sold of $305K offered | filing |
| 2025-06-12 | Private placement (Form D) | $3M sold of $3M offered | filing |
Offering filings
| Filed | Intermediary | Target | Maximum | Deadline | Security | Filing |
|---|---|---|---|---|---|---|
| 2025-09-08 | Dealmaker Securities LLC | $10K | $1.23M | 2026-08-28 | Common Stock | C |
Financials the company filed
Figures from the C filed 2025-09-08, as the company reported them.
| As filed | Most recent fiscal year | Prior fiscal year |
|---|---|---|
| Revenue | $683K | $606K |
| Net income | -$1.76M | -$1.79M |
| Total assets | $626K | $837K |
| Cash and equivalents | $64K | |
| Short-term debt | $498K | |
| Long-term debt | $688K |
Employees at filing: 9.
Revenue went from $606K to $683K (+13%). Net loss was $1.76M, against a loss of $1.79M the year before. It reported $64K in cash and $1.19M in debt. These are the company's own figures from the Form C filed 2025-09-08.
People who signed the filing
- Saif Khalil, PhD, Chairman, CEO, Principal Executive Officer, Principal Accounting, and Principal Financial Officer
- William Shopoff, Director
- David Farmer, Director
- Gerald Williams, Jr., MD, Director
Every filing
| Filed | What it is | Filing |
|---|---|---|
| 2025-09-08 | Offering | C |
What to check before investing
- Read the offering page on Dealmaker Securities LLC: it states the valuation or cap and the minimum investment, which the SEC filing does not.
- Compare the terms above with the numbers: what does the price imply against revenue of $683K?
- Look at who signed the filing and what else they have run (the founder Snapshot below).
- Check the deadline and what happens if the target is missed.
- You cannot easily sell a crowdfunding security; invest only what you can leave tied up.
A crowdfunding round is won in public. FoxPlug turns your commits, deploys and releases into the posts and visuals that keep the story moving while the offering is open.
Build your launch kitRun a Snapshot on Saif Khalil, PhD: other companies, roles and the record behind them. Order Full Report from there if you need more.
Snapshot the foundersTools for this story
Each opens in a new tab, filled in for Aevumed Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company raising money from the public under Regulation Crowdfunding has to file with the SEC before the offering opens, and has to raise through a single registered intermediary: a funding portal or a broker-dealer. The first filing, Form C, states how much the company is trying to raise, the most it will accept, the deadline, the security and its price, the intermediary and what the intermediary is paid, and two years of the company's own financial figures.
After that the company files amendments when terms change, progress updates as the raise moves, and an annual report each year until it stops reporting. Every row here is one of those filings, linked to the filing itself, so each figure can be checked at the source. Figures are exactly as the company filed them; where a filing leaves a field blank, so does this page. Nothing here is investment advice, and a filing is the company's own statement, not a verification of it.